Your NEJM Group Today: Rejecting Science, Harming Women / Tocilizumab for Giant-Cell Arteritis / NJ Primary Care Opportunities (FREE)

By the Editors Take a look at today ' s offering from NEJM Group:NEJM Audio Interview: Rejecting Science, Harming …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news